Covid-19 vaccines: latest on research

There are currently more than 320 possible Covid-19 vaccines in development, with some now approved for use. This is a historic moment and the result of a global, collaborative research effort. 

Some of the cutting-edge methods used during this outbreak could revolutionise vaccine development in future.

Without vaccines, distributed equitably all over the world, we could face recurring waves of Covid-19.


A hand in a medical glove holds the Covid-19 vaccine, it is connected to an image of the globe by an orange line.

Covid-19 vaccines: information hub

A collection of quick and simple resources on how Covid-19 vaccines work, how we know they're safe, and how they can be distributed to everyone around the world.

More explainers

Read more news and opinions on Covid-19 and visit our YouTube channel(opens in a new tab)

How we're supporting research 

We’re supporting global vaccine research and development efforts through CEPI, the Coalition for Epidemic Preparedness Innovations(opens in a new tab)

CEPI is currently funding the development of nine Covid-19 vaccines. Several are in phase III clinical trials.

We’re also calling for governments, businesses and philanthropy to support the Covid-19 vaccine process, from research and development to manufacturing and delivery – to make sure that there are enough vaccines available for everyone who needs one. The funds raised so far are a positive first step, but greater investment is needed

Vaccines for everyone 

Fair global vaccine allocation is the only way to end the Covid-19 pandemic. Jeremy Farrar, Director of Wellcome, explains why world leaders need to recognise this and ensure a truly global vaccination programme is made available to everyone as fast as possible.

There will be huge demand from countries around the world, and any new Covid-19 vaccines must first be made available to those who need them most, not just those who can afford to buy them.

Pooling money and expertise will be the fastest, most effective way to end the pandemic. Organisations like Gavi, UNICEF and the World Health Organization, and global collaborations like the ACT Accelerator(opens in a new tab) and the COVID-19 Vaccine Global Access Facility (COVAX)(opens in a new tab), will play a vital role in ensuring access to a Covid-19 vaccine alongside the life-saving vaccines we already have. 

Contact us 

To contact someone in the team, email

See who’s who in the vaccines team

Related content